ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Emerenciano, Mariana ^a   Barbosa, Thayana C ^a   Lopes, Bruno A ^a   Blunck, Caroline B ^a   Faro, Alessandra ^a   Andrade, Camilla ^a   Meyer, Claus ^b   Marschalek, Rolf ^b   Pombo de Oliveira, Maria S ^a   Magalhães, Isis Qulesado ^c   Cordoba, José Carlos ^c   Lafayette, Theresa Christina ^d   Cóser, Virginia Maria ^d   Dorea, Maria D ^e   Araujo, Flavia N Serafim ^e   Burlachini, Lilian Maria ^e   Nobrega, Andrea Gadelha ^f   Fialho, Eloisa C E ^f   Pimenta, Flavia Cristina F ^f   Mamede, Glaceanne Torres da Luz ^f   Salles, Terezinha de Jesus Marques ^g   Dobbin, Jane ^a   Apa, Alexandre ^a   Brandalise, Silvia ^h   Pinheiro, Vitória R ^h   Souza, Adriana Martins de ⁱ   Rouxinol, Soraya ⁱ   Carvalho, Eny G ^j   Da Silva, Ana M Marinho ^j   de Andrade Agareno, Jozina M ^j   Pianovski, Mara A D ^k   Tormen, Tiago Hessel ^k   Brito, Patricia Carneiro de ^l   Oliveira, Loretta S C ^l   Costa, Imarui ^m   Bousfield, Denise ^m   Wernerck, Fernando de Almeida ⁿ   Cardoso, Teresa Cristina ^e   Souza, Marcelo Santos de ^o   Baseggio, Rosania ^o   Melaragno, Renato ^p   Neves, Gustavo ^p   Arancibia M , Alejandro ^q   Cristofani, Lilian Maria ^r   Mendes, Wellington ^s   Da Costa, Cecília M Lima ^s   Ramos, Gilberto ^t   Neto, Joaquim C Aguirre ^t   Lee, Maria Lucia Marinho ^u   De Brito, Nilma Pimentel ^v   Gurgel, Renata S Carvalho ^w   more..

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b GOETHE UNIVERSITY   (Germany)

^c Hospital das Clínicas de Brasília   (Brazil)

^d Hospital Universitário de Santa Maria n 24   (Brazil)

^e Sociedade de Oncologia da Bahia Salvador ^*  (Brazil)

^f Hospital Napoleão Laureano   (Brazil)

^g FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^h Centro Infantil Dr Domingos A Boldrini   (Brazil)

ⁱ Instituto de Puericultura e Pediatria Martagao Gesteira   (Brazil)

^j Hospital Martagão Gesteira   (Brazil)

^k Hospital de Clinicas   (Brazil)

^l Araujo Jorge Hospital   (Brazil)

^m HOSPITAL INFANTIL JOANA DE GUSMÃO   (Brazil)

ⁿ Ophtalmology Service   (Brazil)

^o Hospital Regional Rosa Pedrossian   (Brazil)

^p HOSPITAL SANTA MARCELINA   (Brazil)

^q Hospital Amaral Carvalho   (Brazil)

^r Instituto Da Criança Prof Pedro de Alcântara   (Brazil)

^s A C CAMARGO CANCER CENTER   (Brazil)

^t Hospital das Clinicas Belo Horizonte   (Brazil)

^u Instituto de Oncologia Sao Paulo   (Brazil)

^v Hospital Aristidez Maltez Salvador   (Brazil)

^w Hospital Universitário Alcides Carneiro Campina Grande   (Brazil)

more..

Author keywords

ARID5B; CEBPE; IKZF1; Infant leukemia; MLL

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; ARID5B PROTEIN, HUMAN; DNA BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ALLELE; ARID5B GENE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CEBPE GENE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; GENE; GENE REARRANGEMENT; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GERM LINE; HETEROZYGOTE; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IKZF1 GENE; MAJOR CLINICAL STUDY; MLL GENE; MLL MLLT3 GENE; MUTANT; ONSET AGE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN COLOR; BRAZIL; CASE CONTROL STUDY; CLINICAL TRIAL; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; LEUKEMIA; MULTICENTER STUDY; PRESCHOOL CHILD; RISK;

AGE FACTORS; BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ODDS RATIO; ONCOGENE PROTEINS, FUSION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84896727594     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-127     Document Type: Article

References (32)

1. Pieters R, Schrappe M, de LP, Hann I, De RG, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster A, Janka G, Rubnitz J, Silverman L, Stary J, Campbell M, Li C, Mann G, Suppiah R, Biondi A, Vora A, Valsecchi MG. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007, 370:240-250. 10.1016/S0140-6736(07)61126-X, 17658395.
2. Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009, 114:2489-2496. 10.1182/blood-2009-04-215152, 2927031, 19528532.
3. Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, Greaves M. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993, 363:358-360. 10.1038/363358a0, 8497319.
4. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003, 3:639-649. 10.1038/nrc1164, 12951583.
5. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhães IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 2001, 61:2542-2546.
6. Pombo-de-Oliveira MS, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 2006, 15:2336-2341. 10.1158/1055-9965.EPI-06-0031, 17164354.
7. Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S, Brazilian Collaborative Study Group of Infant Acute Leukemia In utero pesticide exposure and leukemia in Brazilian children < 2 years of age. Environ Health Perspect 2013, 121:269-275. 3569673, 23092909, Brazilian Collaborative Study Group of Infant Acute Leukemia.
8. Vijayakrishnan J, Houlston RS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 2010, 95:1405-1414. 10.3324/haematol.2010.022095, 2913091, 20511665.
9. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF, United Kingdom Childhood Cancer Study investigators Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A 2001, 98:4004-4009. 10.1073/pnas.061408298, 31169, 11274424, United Kingdom Childhood Cancer Study investigators.
10. Smith MT, Wang Y, Skibola CF, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G. Low NAD (P) H: quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002, 100:4590-4593. 10.1182/blood-2001-12-0264, 12393620.
11. Zanrosso CW, Emerenciano M, Goncalves BA, Faro A, Koifman S, Pombo-de-Oliveira MS. N-acetyltransferase 2 polymorphisms and susceptibility to infant leukemia with maternal exposure to dipyrone during pregnancy. Cancer Epidemiol Biomarkers Prev 2010, 19:3037-3043. 10.1158/1055-9965.EPI-10-0508, 20884738.
12. Ross JA, Linabery AM, Blommer CN, Langer EK, Spector LG, Hilden JM, Heerema NA, Radolff GA, Tower RL, Davies SM. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer 2013, 60:31-34. 10.1002/pbc.24131, 3381932, 22422485.
13. Gonçalves BAA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS, Brazilian Collaborative Study Group of Infant Acute Leukemia NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control 2012, 23:1811-1819. 10.1007/s10552-012-0060-5, 22976839, Brazilian Collaborative Study Group of Infant Acute Leukemia.
14. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, Camitta BM, Bowman WP, Willman CL, Carroll WL, Mullighan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML, Yang JJ. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 2013, 105:733-742. 10.1093/jnci/djt042, 23512250.
15. Emerenciano M, Meyer C, Mansur MB, Marschalek R, Pombo-de-Oliveira MS, Brazilian Collaborative Study Group of Infant Acute Leukaemia The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia. Br J Haematol 2013, 161:224-236. 10.1111/bjh.12250, 23432364, Brazilian Collaborative Study Group of Infant Acute Leukaemia.
16. Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S, Schoch C, Jansen MW, van Dongen JJ, Pieters R, Haas OA, Dingermann T, Klingebiel T, Marschalek R. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Pro Natl Acad Sci USA 2005, 102:449-454.
17. Buffler PA, Kwan ML, Reynolds P, Urayama KY. Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest 2005, 23:60-75. 10.1081/CNV-46402, 15779869.
18. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, Houlston RS. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009, 41:1006-1010. 10.1038/ng.430, 19684604.
19. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC, Pui CH, Evans WE, Relling MV. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009, 41:1001-1005. 10.1038/ng.432, 2762391, 19684603.
20. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, Sheridan E, Gast A, Kinsey SE, Lightfoot T, Roman E, Taylor M, Pritchard-Jones K, Stanulla M, Schrappe M, Bartram CR, Houlston RS, Kumar R, Hemminki K. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010, 115:1765-1767. 10.1182/blood-2009-09-241513, 20042726.
21. Pastorczak A, Gorniak P, Sherborne A, Hosking F, Trelińska J, Lejman M, Sczepański T, Borowiec M, Fendler W, Kowalczyk J, Houlston RS, Mynarski W. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 2011, 35:1534-1536. 10.1016/j.leukres.2011.07.034, 21889209.
22. Wang Y, Chen J, Li J, Deng J, Rui Y, Lu Q, Wang M, Tong N, Zhang Z, Fang Y. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Gene 2013, 524:203-207. 10.1016/j.gene.2013.04.028, 23608171.
23. Chokkalingam AP, Hsu L, Metayer C, Hansen HM, Month SR, Barcellos LF, Wiemels JL, Buffler PA. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control 2013, 24:1789-1795. 10.1007/s10552-013-0256-3, 3771434, 23836053.
24. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 2010, 95:1608-1611. 10.3324/haematol.2010.022459, 2930966, 20460642.
25. Lautner-Csorba O, Gezsi A, Semsei AF, Antal P, Erdélyi DJ, Schermann G, Kutszegi N, Csordás K, Hegyi M, Kovács G, Falus A, Szalai C. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics 2012, 5:42. 10.1186/1755-8794-5-42, 3542204, 23021489.
26. Patsialou A, Wilsker D, Moran E. DNA-binding properties of ARID family proteins. Nucleic Acids Res 2005, 33:66-80. 10.1093/nar/gki145, 546134, 15640446.
27. Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, Baruchel A, Cavé H, Dastugue N, Hasle H, Kaspers GL, Lessard M, Michaux L, Vyas P, van Wering E, Zwaan CM, Golub TR, Orkin SH. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci U S A 2006, 103:3339-3344. 10.1073/pnas.0511150103, 1413912, 16492768.
28. Chang LW, Payton JE, Yuan W, Ley TJ, Nagarajan R, Stormo GD. Computational identification of the normal and perturbed genetic networks involved in myeloid differentiation and acute promyelocytic leukemia. Genome Biol 2008, 9:R38. 10.1186/gb-2008-9-2-r38, 2374711, 18291030.
29. Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic aspects of infant leukemia. Blood 2000, 96:24-33.
30. Emerenciano M, Agudelo Arias DP, Coser VM, de Brito GD, Macedo Silva ML, Pombo-de-Oliveira MS. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. Pediatr Blood Cancer 2006, 47:549-554. 10.1002/pbc.20654, 16261608.
31. Rudant J, Orsi L, Bonaventure A, Goujon-Bellec S, Corda E, Baruchel A, Bertrand Y, Nelken B, Robert A, Michel G, Sirvent N, Chastagner P, Ducassou S, Rialland X, Hémon D, Leverger G, Clavel J. Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE). Leukemia 2013, 27:746-748. 10.1038/leu.2012.244, 22922568.
32. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo De Oliveira M, Renneville A, Villarese P, Macintyre E, Cave H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VHJ, van Dongen JJM, Delabesse E, Binato R, Silva MLM, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V. The MLL recombinome of acute leukemias in 2013. Leukemia 2013, 27:2165-2176. 10.1038/leu.2013.135, 3826032, 23628958.